Stifel Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
18,177
-310
| -2% | -$19.6K | ﹤0.01% | 2234 |
|
|
2025
Q1 | $979K | Sell |
18,487
-1,029
| -5% | -$54.5K | ﹤0.01% | 2251 |
|
|
2024
Q4 | $1.09M | Sell |
19,516
-326
| -2% | -$18.3K | ﹤0.01% | 2193 |
|
|
2024
Q3 | $1.04M | Sell |
19,842
-8,216
| -29% | -$430K | ﹤0.01% | 2199 |
|
|
2024
Q2 | $1.15M | Buy |
28,058
+121
| +0.4% | +$4.97K | ﹤0.01% | 2080 |
|
|
2024
Q1 | $1.21M | Sell |
27,937
-2,688
| -9% | -$116K | ﹤0.01% | 2063 |
|
|
2023
Q4 | $1.41M | Sell |
30,625
-15,365
| -33% | -$706K | ﹤0.01% | 1917 |
|
|
2023
Q3 | $1.05M | Sell |
45,990
-706
| -2% | -$16.2K | ﹤0.01% | 2019 |
|
|
2023
Q2 | $770K | Buy |
46,696
+25,206
| +117% | +$416K | ﹤0.01% | 2245 |
|
|
2023
Q1 | $383K | Buy |
21,490
+2,110
| +11% | +$37.6K | ﹤0.01% | 2673 |
|
|
2022
Q4 | $564K | Sell |
19,380
-200
| -1% | -$5.82K | ﹤0.01% | 2402 |
|
|
2022
Q3 | $480K | Buy |
19,580
+619
| +3% | +$15.2K | ﹤0.01% | 2456 |
|
|
2022
Q2 | $79K | Sell |
18,961
-7,405
| -28% | -$30.9K | ﹤0.01% | 3186 |
|
|
2022
Q1 | $303K | Sell |
26,366
-47,547
| -64% | -$546K | ﹤0.01% | 2878 |
|
|
2021
Q4 | $738K | Sell |
73,913
-60,673
| -45% | -$606K | ﹤0.01% | 2343 |
|
|
2021
Q3 | $1.76M | Sell |
134,586
-46,828
| -26% | -$611K | ﹤0.01% | 1666 |
|
|
2021
Q2 | $3.55M | Buy |
181,414
+64,181
| +55% | +$1.26M | 0.01% | 1214 |
|
|
2021
Q1 | $2.49M | Buy |
117,233
+105,579
| +906% | +$2.25M | ﹤0.01% | 1378 |
|
|
2020
Q4 | $347K | Buy |
+11,654
| New | +$347K | ﹤0.01% | 2527 |
|
|
2018
Q3 | – | Sell |
-8,538
| Closed | -$266K | – | 2810 |
|
|
2018
Q2 | $266K | Buy |
+8,538
| New | +$266K | ﹤0.01% | 2373 |
|